3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Sarcoma
23
Lymphoma
16
Osteosarcoma
11
Lymphoma, Large B-Cell, Diffuse
11
Hodgkin Disease
11
Testicular Neoplasms
10
Lymphoma, Non-Hodgkin
10
Teratoma
8
Ovarian Neoplasms
7
Testicular Germ Cell Tumor
6
Neuroectodermal Tumors, Primitive, Peripheral
6
Neoplasms
6
Burkitt Lymphoma
6
Recurrence
5
Endodermal Sinus Tumor
5
Central Nervous System Neoplasms
5
Carcinoma, Embryonal
5
Lymphoma, Large-Cell, Anaplastic
4
Seminoma
3
Rhabdomyosarcoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Ovarian Germ Cell Cancer
3
Neurofibrosarcoma
3
Lymphoma, Mantle-Cell
3
Lymphoma, B-Cell
3
Histiocytoma, Malignant Fibrous
3
Fibrosarcoma
3
Vomiting
2
Sarcoma, Synovial
2
Sarcoma, Alveolar Soft Part
2
Interventions
tremelimumab
1
trametinib
1
pazopanib
1
eribulin
1
durvalumab
1
HhAntag691
1
Gemcitabine
1
2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Hemangioendothelioma, Epithelioid
×
Ifosfamide
×
Clear all
No trials found.